IMV INC Current Ratio 2017-2019 | IMV

IMV INC current ratio from 2017 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
IMV INC Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.02B $0.01B 4.47
2019-06-30 $0.03B $0.00B 5.74
2019-03-31 $0.03B $0.00B 7.03
2018-12-31 $0.02B $0.01B 2.57
2018-09-30 $0.02B $0.00B 4.86
2018-06-30 $0.02B $0.00B 6.49
2018-03-31 $0.02B $0.00B 12.01
2017-12-31 $0.01B $0.00B 5.80
2017-09-30 $0.02B $0.00B 11.87
2017-06-30 $0.02B $0.00B 10.18
2017-03-31 $0.01B $0.00B 9.98
2016-12-31 $0.01B $0.00B 8.21
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.119B $0.000B
IMV Inc. is a clinical-stage immuno-oncology company. Its proprietary drug development platform provides a patented delivery formulation which enables controlled and prolonged exposure of antigens to the immune system. The company's pipeline consists of DPX-Survivac, DPX-E7 and DPX-RSV which are in clinical stage. IMV Inc. is based in Halifax, Canada.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.901B 10.10
Zoetis (ZTS) United States $57.261B 34.25
Astellas Pharma (ALPMY) Japan $31.581B 15.77
Eisai (ESALY) Japan $20.389B 39.31
UCB SA (UCBJF) Belgium $15.697B 0.00
Merck (MKGAF) Germany $15.446B 21.08
Grifols, S.A (GRFS) Spain $15.250B 19.46
Neurocrine Biosciences (NBIX) United States $10.476B 494.57
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.886B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.493B 17.20
Jazz Pharmaceuticals (JAZZ) Ireland $8.069B 10.31
Sage Therapeutics (SAGE) United States $7.865B 0.00
Catalent (CTLT) United States $7.542B 30.68
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.263B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.203B 18.70
Arrowhead Pharmaceuticals (ARWR) United States $4.652B 106.65
United Therapeutics (UTHR) United States $4.099B 0.00
Nektar Therapeutics (NKTR) United States $3.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.503B 12.80
FibroGen (FGEN) United States $3.304B 97.10
Evotec AG (EVTCY) Germany $3.079B 50.38
PTC Therapeutics (PTCT) United States $2.643B 0.00
Tilray (TLRY) Canada $2.249B 0.00
Portola Pharmaceuticals (PTLA) United States $2.227B 0.00
Heron Therapeutics (HRTX) United States $2.198B 0.00
Xencor (XNCR) United States $2.180B 66.26
Zogenix (ZGNX) United States $2.034B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.874B 59.75
Pacira Pharmaceuticals (PCRX) United States $1.839B 54.42
USANA Health Sciences (USNA) United States $1.540B 16.43
Corcept Therapeutics (CORT) United States $1.482B 18.01
Enanta Pharmaceuticals (ENTA) United States $1.250B 28.61
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Radius Health (RDUS) United States $1.081B 0.00
Endo (ENDP) Ireland $1.032B 1.90
ArQule (ARQL) United States $1.026B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.016B 0.00
Karyopharm Therapeutics (KPTI) United States $1.011B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.977B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.909B 6.20
Aerie Pharmaceuticals (AERI) United States $0.852B 0.00
TherapeuticsMD (TXMD) United States $0.719B 0.00
Collegium Pharmaceutical (COLL) United States $0.644B 0.00
Flexion Therapeutics (FLXN) United States $0.643B 0.00
Translate Bio (TBIO) United States $0.643B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.587B 0.00
Organogenesis Holdings (ORGO) United States $0.575B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
ChemoCentryx (CCXI) United States $0.485B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.457B 0.00
Dermira (DERM) United States $0.451B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.448B 54.38
Akebia Therapeutics (AKBA) United States $0.412B 0.00
Siga Technologies (SIGA) United States $0.410B 9.37
Ardelyx (ARDX) United States $0.403B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.396B 17.09
Recro Pharma (REPH) United States $0.396B 0.00
OptiNose (OPTN) United States $0.391B 0.00
Harpoon Therapeutics (HARP) United States $0.378B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 0.00
Molecular Templates (MTEM) United States $0.373B 0.00
Indivior (INVVY) United States $0.367B 1.33
Lannett Co Inc (LCI) United States $0.357B 4.15
DURECT (DRRX) United States $0.342B 0.00
Innate Pharma SA (IPHYF) France $0.338B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.332B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.308B 0.00
Rafael Holdings (RFL) United States $0.289B 0.00
GlycoMimetics (GLYC) United States $0.231B 0.00
KalVista Pharmaceuticals (KALV) United States $0.229B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.217B 0.00
Xeris Pharmaceuticals (XERS) United States $0.209B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.203B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.190B 0.00
Nature's Sunshine Products (NATR) United States $0.187B 32.20
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Concert Pharmaceuticals (CNCE) United States $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.159B 2.12
Aquestive Therapeutics (AQST) United States $0.155B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.153B 0.00
CV Sciences (CVSI) United States $0.144B 0.00
Ocular Therapeutix (OCUL) United States $0.142B 0.00
CannTrust Holdings (CTST) Canada $0.135B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
MEI Pharma (MEIP) United States $0.132B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.128B 0.00
Redhill Biopharma (RDHL) Israel $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.088B 0.00
Majesco Entertainment (PTE) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.073B 21.77
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Capnia (SLNO) United States $0.066B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Pharmaxis (PXSLY) Australia $0.061B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.060B 0.00
Generex Biotechnology (GNBT) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.058B 0.00
Natural Alternatives (NAII) United States $0.057B 14.21
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.056B 0.00
AgeX Therapeutics (AGE) United States $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.054B 0.00
Novan (NOVN) United States $0.053B 0.00
RENEURON GP (RNUGF) United Kingdom $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.045B 0.00
CTI BioPharma (CTIC) United States $0.042B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
Biomerica (BMRA) United States $0.028B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
IsoRay (ISR) United States $0.028B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
VAXART, INC (VXRT) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Onconova Therapeutics (ONTX) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00